GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » PB Ratio

HPGC Renmintongtai Pharmaceutical (SHSE:600829) PB Ratio : 1.71 (As of Dec. 12, 2024)


View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-12), HPGC Renmintongtai Pharmaceutical's share price is ¥8.47. HPGC Renmintongtai Pharmaceutical's Book Value per Share for the quarter that ended in Sep. 2024 was ¥4.96. Hence, HPGC Renmintongtai Pharmaceutical's PB Ratio of today is 1.71.

The historical rank and industry rank for HPGC Renmintongtai Pharmaceutical's PB Ratio or its related term are showing as below:

SHSE:600829' s PB Ratio Range Over the Past 10 Years
Min: 1.07   Med: 2.29   Max: 11.23
Current: 1.71

During the past 13 years, HPGC Renmintongtai Pharmaceutical's highest PB Ratio was 11.23. The lowest was 1.07. And the median was 2.29.

SHSE:600829's PB Ratio is ranked better than
63.44% of 941 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs SHSE:600829: 1.71

During the past 12 months, HPGC Renmintongtai Pharmaceutical's average Book Value Per Share Growth Rate was 6.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 2.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of HPGC Renmintongtai Pharmaceutical was 28.00% per year. The lowest was -18.00% per year. And the median was 7.30% per year.

Back to Basics: PB Ratio


HPGC Renmintongtai Pharmaceutical PB Ratio Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical PB Ratio Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.14 2.16 1.77 1.50 1.65

HPGC Renmintongtai Pharmaceutical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.69 1.65 1.35 1.16 1.27

Competitive Comparison of HPGC Renmintongtai Pharmaceutical's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPGC Renmintongtai Pharmaceutical's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's PB Ratio distribution charts can be found below:

* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's PB Ratio falls into.



HPGC Renmintongtai Pharmaceutical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

HPGC Renmintongtai Pharmaceutical's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=8.47/4.956
=1.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


HPGC Renmintongtai Pharmaceutical  (SHSE:600829) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


HPGC Renmintongtai Pharmaceutical PB Ratio Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HPGC Renmintongtai Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Executives
Yue Xian Zhi senior management
Zhang Li Jun Director

HPGC Renmintongtai Pharmaceutical Headlines

No Headlines